Sarchem Labs is a leading provider in custom synthesis solutions and specialty lab chemicals since 1984. With a combined 60 years of professional experience in pharmaceutical intermediaries, specializing in custom synthesis, the company was founded as a research center focused on anti-viral drugs. Over the years, it has expanded its offerings to cater to the needs of the pharmaceutical, nutraceutical, and medicinal industries, offering an extensive product list cultivated with passion and precision. Serving clients such as CROs, universities, government entities, and pharmaceutical companies of varying sizes, Sarchem Laboratories has established itself as a top-quality custom synthesis provider globally for over 25 years. The company operates within the industries of Biotechnology, Industrial, Life Sciences, Manufacturing, and Pharmaceutical. While the specific location of its headquarters and details about its last investment and investors are not available at this time, the company's rich history and expertise in the field make it an intriguing prospect for potential investment or partnership opportunities.
There is no investment information
No recent news or press coverage available for Sarchem Labs.